Skip to main content
Home

Top menu infoNTD

  • About InfoNTD
  • News & Events
  • e-learning.infoNTD.org
Home

Main navigation InfoNTD

  • NTDs [14]
    • Buruli ulcer
    • Chagas disease
    • Dracunculiasis
    • Human African trypanosomiasis
    • Leishmaniasis
    • Leprosy
    • Lymphatic filariasis
    • Mycetoma
    • Onchocerciasis
    • Schistosomiasis
    • Snakebite envenoming
    • Soil-transmitted helminthiasis
    • Trachoma
    • Yaws
  • Cross-cutting issues [13]
    • Data management & analysis [3]
      • Data collection and reporting
      • Mapping
      • Indicators
    • Integrated wound management
    • Capacity strengthening
    • Management of disease complications [2]
      • Medical management
      • Surgical management
    • Prevention of disability [3]
      • Eye care
      • Self-care
      • Disability measurement
    • Physical rehabilitation [3]
      • Physical therapy
      • Orthopaedic footwear
      • Protheses, walking devices and wheelchairs
    • Stigma and mental wellbeing [1]
      • Mental wellbeing project mapping
    • Inclusion [2]
      • Community-based rehabilitation
      • Gender
    • WASH and NTDs
    • Health systems factors
    • Skin-NTDs
    • Preventive Chemotherapy
    • Health education
  • Toolkits [5]
    • Guides on Stigma and Mental Wellbeing [5]
      • Guide 1. What are health-related stigma and mental wellbeing? [8]
        • 1. What is stigma?
        • 2. Why does stigma exist?
        • 3. What are the causes of stigma?
        • 4. Who stigmatises?
        • 5. How does it feel to experience stigma?
        • 6. What are the effects of stigma?
        • 7. Effects of stigma and discrimination on mental wellbeing
        • Annex Guide 1
      • Guide 2. How to reduce the impact of stigma [7]
        • 1. From undetected disease to diagnosis to support
        • 2. Individual-level interventions
        • 3. Group-level interventions
        • 4. Family-level interventions
        • 5. Referral
        • 6. Further reading
        • Annexes Guide 2
      • Guide 3. How to reduce sources of stigma [6]
        • 1. Background to the design of a stigma-reduction intervention
        • 2. Identifying the sources of stigma
        • 3. Targeting an intervention
        • 4. Inclusion of affected persons and champions in interventions
        • 5. Interventions by source type
        • Annexes Guide 3
      • Guide 4. How to assess health-related stigma and mental wellbeing [9]
        • 1. What is the purpose of the assessment?
        • 2. What approach would best fit your purpose and context?
        • 3. Quantitative assessment methods
        • 4. Qualitative assessment methods
        • 5. Assessments using mixed methods
        • 6. Developing qualitative methods from scratch
        • 7. How do you conduct a stigma assessment?
        • 8. How to interpret and report your findings
        • Annexes Guide 4
      • Glossary
    • Perception Study Toolkit (PST)
    • NTD Morbidity and Disability Measurement Toolkit [15]
      • CHIEF
      • Clinical Profile
      • EMIC affected persons
      • EMIC-CS Community Stigma
      • Participation Scale
      • Patient Health Questionnaire (PHQ-9)
      • 5-Question Stigma Indicators
      • Salsa Scale
      • SARI Stigma Scale
      • SDS Social Distance Scale
      • SRQ Self-reporting Questionnaire
      • Warwick-Edinburgh Mental Wellbeing Scale (WEMWBS)
      • WGQ Washington Group Questions
      • WHODAS
      • WHOQOL-BREF
    • NTD Toolbox
    • CBM's Community Mental Health Good Practice Guides
  • Online courses

Top menu infoNTD

  • About InfoNTD
  • News & Events
  • e-learning.infoNTD.org
Visit our e-learning platform
Search resources Search in Practical Materials, Publications, Organizations, Online Course and more
Publication

Improving the Health and Wellbeing of People Living with Neglected Tropical Diseases through Rehabilitation and Assistive Technology

World Health Organization . World Health Organization. 2022;
Download PDF
Publication

Implementation of mHealth Interventions for Public Healthcare in East Africa

Ndayizigamiye P. IGI Global. Advances in Healthcare Information Systems and Administration. 2022;
Publication

Simulating the effect of evaluation unit size on eligibility to stop mass drug administration for lymphatic filariasis in Haiti

Kostandova N, Desir L, Direny A, et al. Public Library of Science (PLoS). PLOS Neglected Tropical Diseases. 2022; 16 (1) : e0010150.
Download PDF
Publication

Ending the neglect to attain the Sustainable Development Goals - One Health: Approach for action against neglected tropical diseases 2021–2030

World Health Organization . World Health Organization. 2022;
Download PDF
Publication

Parasites causing cutaneous wounds: Theory and practice from a dermatological point of view

Oranges T, Veraldi S, Granieri G, et al. Elsevier BV. Acta Tropica. 2022;
Publication

Ivermectin for COVID-19: Addressing Potential Bias and Medical Fraud

Hill A, Mirchandani M, Pilkington V. Oxford University Press (OUP). Open Forum Infectious Diseases. 2022;
Download PDF
Publication

How Can “Community Voices” from Qualitative Research Illuminate Our Understanding of the Implementation of the SDGs? A Scoping Review

Mbah MF, East LA. MDPI AG. Sustainability. 2022; 14 (4) : 2136.
Download PDF
Publication

The Impact of Unconditional Cash Transfers on Morbidity and Health Seeking Behaviour in Africa: Evidence from Ghana, Malawi, Zambia and Zimbabwe

Novignon J, Prencipe L, Molotsky A, et al. Oxford University Press (OUP). Health Policy and Planning. 2022;
Download PDF
Publication

WHO GUIDELINE on control and elimination of human schistosomiasis

World Health Organization . World Health Organization. 2022;
Download PDF
Publication

Navigating the way to onchocerciasis elimination: the feasibility and cost of onchocerciasis elimination mapping

Hamill L, Trotignon G, Mackenzie C, et al. Oxford University Press (OUP). International Health. 2022;
Download PDF

Pagination

  • Previous page ‹ ‹ Previous
  • …
  • Page 386
  • Page 387
  • Page 388
  • Page 389
  • Current page 390
  • Page 391
  • Page 392
  • Page 393
  • Page 394
  • …
  • Next page Next › ›
  • Last page Last » »
Subscribe to

Quick Links

  • Toolbox
  • Publications
  • Organizations
  • NTDs

Support

  • Contact
  • FAQ
  • Privacy statement

Contact us infoNTD

info@InfoNTD.org

(+31) 20 595 0526

     

Stay up to date with the latest developments in NTDs. We share a monthly overview via email showing a selection of the latest NTD publications and tools. 

Subscribe

Related websites:

© 2026 InfoNTD